These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15552394)

  • 1. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis.
    Murray E; McAdam R; Burke MT
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmaceutical industry and oncology in central and eastern Europe.
    Ben-Am M; Gemperli B; Covelli A; Burke G
    Ann Oncol; 1999; 10 Suppl 6():15-7. PubMed ID: 10676548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal drug trials: impact of EU and US paediatric regulations.
    Pansieri C; Bonati M; Choonara I; Jacqz-Aigrain E
    Arch Dis Child Fetal Neonatal Ed; 2014 Sep; 99(5):F438. PubMed ID: 24792777
    [No Abstract]   [Full Text] [Related]  

  • 4. Good pharma? Bad pharma? Better pharma.
    Hardman M
    J R Coll Physicians Edinb; 2014; 44(4):269-72. PubMed ID: 25516893
    [No Abstract]   [Full Text] [Related]  

  • 5. New European clinical trial regulations are "unacceptable" to industry.
    Davidson S
    Nat Biotechnol; 1998 Feb; 16(2):127. PubMed ID: 9487504
    [No Abstract]   [Full Text] [Related]  

  • 6. Transparency battle resurfaces as EU trial revamp wraps up.
    Holmes D
    Nat Med; 2013 Jul; 19(7):797. PubMed ID: 23836204
    [No Abstract]   [Full Text] [Related]  

  • 7. The EU Clinical Trials Regulation: key priorities, purposes and aims and the implications for public health.
    Flear ML
    J Med Ethics; 2016 Mar; 42(3):192-8. PubMed ID: 26831742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness. Commentary.
    Amato A; Aringhieri E; Boccia S; Buccella F; Gorini B; Gramaglia D; Masetti R; Rossi P; Pelicci PG
    Ann Ist Super Sanita; 2017; 53(2):104-107. PubMed ID: 28617255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-marketing authorisation submission assessments in Europe.
    Morgan L
    Therapie; 2005; 60(3):205-8. PubMed ID: 16128260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globalization of clinical research by the pharmaceutical industry.
    Shah S
    Int J Health Serv; 2003; 33(1):29-36. PubMed ID: 12641261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the European clinical trials directive really improve clinical trial approval time?
    Lambers Heerspink HJ; Dobre D; Hillege HL; Grobbee DE; de Zeeuw D
    Br J Clin Pharmacol; 2008 Oct; 66(4):546-50. PubMed ID: 18662290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
    Bilbault P; Belorgey C; Zannad F; Golinelli D; Pletan Y;
    Therapie; 2010; 65(4):301-8, 291-9. PubMed ID: 20854751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European drug industry concerned over proposed clinical-trial legislation.
    Rogers A
    Lancet; 1997 Nov; 350(9091):1609. PubMed ID: 11655209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research ethics committees in Europe: implementing the directive, respecting diversity.
    Hedgecoe A; Carvalho F; Lobmayer P; Raka F
    J Med Ethics; 2006 Aug; 32(8):483-6. PubMed ID: 16877630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal products in the European Union--between harmonization and divergence.
    Lojko N
    Med Law; 2010 Mar; 29(1):61-76. PubMed ID: 22457998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New European regulation for clinical trials of medicinal products.
    Lemaire F; Matei M; Juvin P
    Am J Respir Crit Care Med; 2015 Jan; 191(1):16-8. PubMed ID: 25551347
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ethics Review Boards discriminate the most severely ill--Swedish researchers are prevented to participate in an international study].
    Björck M; Berg B; Hedin U; Wingren U
    Lakartidningen; 2010 May 26-Jun 1; 107(21):1356-7. PubMed ID: 20645608
    [No Abstract]   [Full Text] [Related]  

  • 19. Harmonization in the regulation of pharmaceutical research and human rights: the need to think globally.
    Dominguez-Urban I
    Cornell Int Law J; 1997; 30(2):245-86. PubMed ID: 12194190
    [No Abstract]   [Full Text] [Related]  

  • 20. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.